Patents by Inventor Michael Romanowski

Michael Romanowski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11066469
    Abstract: This disclosure relates to anti-Natriuretic Peptide Receptor 1 (NPR1) antibodies including agonist antibodies which are able to activate the NPR1 receptor, pharmaceutical compositions comprising the same, and methods of treatment comprising the same.
    Type: Grant
    Filed: June 10, 2020
    Date of Patent: July 20, 2021
    Assignee: NOVARTIS AG
    Inventors: John Louis Diener, Lars Gadtke, Felix Hartlepp, Kathrin Ladetzki-Baehs, Michael Romanowski, Cesare Russo, Xenia Wezler
  • Publication number: 20200392225
    Abstract: This disclosure relates to anti-Natriuretic Peptide Receptor 1 (NPR1) antibodies including agonist antibodies which are able to activate the NPR1 receptor, pharmaceutical compositions comprising the same, and methods of treatment comprising the same.
    Type: Application
    Filed: June 10, 2020
    Publication date: December 17, 2020
    Inventors: John Louis DIENER, Lars GADTKE, Felix HARTLEPP, Tiancen HU, Kathrin LADETZKI-BAEHS, Michael ROMANOWSKI, Cesare RUSSO, Xenia WEZLER, Xiaoling XIE
  • Publication number: 20080020412
    Abstract: The present invention is directed to Aurora constructs that are useful for structural and functional studies of Aurora. Specifically, engineered Aurora enzymes are provided, along with polynucleotides encoding said enzymes, vectors comprising said polynucleotides, and host cells comprising the vectors. In addition, a process of using the engineered Aurora enzymes to identify Aurora modulators is provided.
    Type: Application
    Filed: January 3, 2007
    Publication date: January 24, 2008
    Inventors: Michael Romanowski, L Randal